The gravity of the threat posed by vivax malaria to public health has been poorly
appreciated. The widely held misperception of Plasmodium vivax as being relatively …

Background Multidrug-resistant Plasmodium vivax (Pv) is widespread in eastern Indonesia,
and emerging elsewhere in Asia-Pacific and South America, but is generally regarded as a …

Background Severe malaria (SM) is classically associated with Plasmodium falciparum
infection. Little information is available on the contribution of P. vivax to severe disease …

Background Malaria control is difficult where there is intense year-round transmission of
multiple plasmodium species, such as in Papua New Guinea. Methods Between April 2005 …

Background. Multidrug-resistant strains of Plasmodium vivax are emerging in Southeast
Asia. Methods. In vitro drug susceptibility and pvmdr1 genotype were determined in P. vivax …

Background: Malaria is the most important parasitic disease and its control depends on
specific chemotherapy, now complicated by Plasmodium falciparum that has become …

No data were available concerning Plasmodium vivax resistance to chloroquine (CQ) in
Madagascar. We investigated the therapeutic efficacy of CQ in P. vivax malaria, the …

Background Many antimalarial interventions are accompanied by molecular monitoring of
parasite infections, and a number of molecular typing techniques based on different …

Molecular markers associated with the increase of chloroquine resistance and disease
severity in Plasmodium vivax are needed. The objective of this study was to evaluate the …

Background. Molecular markers for sulfadoxine-pyrimethamine (SP) resistance in
Plasmodium vivax have been reported. However, data on the molecular correlates involved …